| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |